# Novartis AG: Form 6-K, filed Sep 1, 2026

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2026-09-01
- Accepted by EDGAR: Sep 1, 2026, 06:21 ET
- Period: 2026-09-01
- Accession: 0001171843-26-005824
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000117184326005824/f6k_090126.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000117184326005824/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000117184326005824/f6k_090126.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-005824. Last ingested by Listed: Nov 13, 2026, 16:23 ET. No prices; not investment advice.
